Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Pancreatic Neoplasms. Found 36 abstracts

no pagination
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algul H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England journal of medicine. 2019 Jul 25;381(4):317-27.   PMCID: PMC6810605
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Gerson JN, Witteles RM, Chang DT, Beygui RE, Iagaru AH, Kunz PL. Carcinoid Syndrome Complicating a Pancreatic Neuroendocrine Tumor: A Case Report. Pancreas. 2017 Nov;46(10):1381-5.
Ursu O, Gosline SJ, Beeharry N, Fink L, Bhattacharjee V, Huang SC, Zhou Y, Yen T, Fraenkel E. Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens. PLoS One. 2017 Oct;12(10):e0185650.   PMCID: PMC5638242
Burtness B, Powell M, Catalano P, Berlin J, Liles DK, Chapman AE, Mitchell E, Benson AB. Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study. Am J Clin Oncol. 2016 Aug;39(4):340-5.   PMCID: PMC4177955
Hoffman JP, Reddy SS. Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma?. J Oncol Pract. 2016 Sep;12(9):780-1.   PMCID: Letter
Li D, Moughan J, Crane C, Hoffman JP, Regine WF, Abrams RA, Safran H, Liu C, Chang P, Freedman GM, Winter KA, Guha C, Abbruzzese JL. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy Oncology Group 9704. Int J Radiat Oncol Biol Phys. 2016 Mar;94(3):554-60.   PMCID: PMC4876948
Chen KT, Devarajan K, Hoffman JP. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2015 Apr;22(4):1185-9.
Moayyedi P, Weinberg DS, Schunemann H, Chak A. Management of pancreatic cysts in an evidence-based world [Comment]. Gastroenterology. 2015 Apr;148(4):692-5.   PMCID: Comment
Wang LS, Shaikh T, Handorf EA, Hoffman JP, Cohen SJ, Meyer JE. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Practical radiation oncology. 2015 Sep;5(5):e457-63.   PMCID: 4814166
Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL. Quality indicators for EUS. Gastrointestinal endoscopy. 2015 Jan;81(1):67-80.
Lal S, Burkhart RA, Beeharry N, Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris ZA, Yeo CJ, Sawicki JA, Winter JM, Rigoutsos I, Yen TJ, Brody JR. HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells. Cancer Res. 2014 Feb 15;74(4):1128-40.   PMCID: 4353573
Li J, Lang J, Wang P, Kang S, Lin MH, Chen X, Chen F, Guo M, Chen L, Ma CM. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques. Medical Dosimetry. 2014 Jan;39(4):330-6.
Reddy SS, Hoffman JP. "Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of borderline resectable disease": a commentary on the article published by Kelly et al. In the Journal of Gastrointestinal Surgery 17:1209 (2013) [Comment; Letter]. J Gastrointest Surg. 2014 Sep;18(9):1719.
Tokar JL, Walia R. Diagnostic evaluation of solid pancreatic masses. Current gastroenterology reports. 2013 Oct;15(10):347.
Canter D, Simhan J, Smaldone MC, Lebed B, Tokar JL, Wu KN, Uzzo RG, Gustafson KS, Patchefsky AS, Plimack ER, Hoffman JP, Kutikov A. Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas. Urology. 2012 Feb;79(2):e9-10.   PMCID: not NIH funded
Milone L, Okhunov Z, Gumbs AA. Laparoscopic diagnosis of annular pancreas in a patient with mucinous cystoadenoma of the body of the pancreas. J Gastrointest Cancer. 2012 Jun;43(2):367-9.   PMCID: not NIH funded
Small W, Berlin J, Freedman GM, Lawrence T, Talamonti MS, Mulcahy MF, Chakravarthy AB, Konski AA, Zalupski MM, Philip PA, Kinsella TJ, Merchant NB, Hoffman JP, Benson AB, Nicol S, Xu RM, Gill JF, McGinn CJ. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008 Feb 20;26(6):942-7.
Stitzenberg KB, Watson JC, Roberts A, Kagan SA, Cohen SJ, Konski AA, Hoffman JP. Survival after pancreatectomy with major arterial resection and reconstruction. Ann Surg Oncol. 2008 May;15(5):1399-406.
Cordera F, Arciero CA, Li T, Watson JC, Hoffman JP. Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol. 2007 Aug;14(8):2330-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Pancreatic Neoplasms

Pancreatic Neoplasms Female Male Adenocarcinoma Aged pathology Middle Aged Adult surgery Neoplasm Staging diagnosis methods 80 and over Aged therapeutic use therapy mortality analogs & derivatives genetics Survival Rate adverse effects Pancreaticoduodenectomy Prognosis drug therapy Deoxycytidine complications etiology Pancreatic Diseases Chemoradiotherapy secondary administration & dosage Disease-Free Survival Treatment Outcome Neoadjuvant Therapy Endoscopic Ultrasound-Guided Fine Needle Aspiration Prospective Studies Adjuvant Radiotherapy drug effects drug Hepatic Artery Survival Analysis CA-19-9 Antigen blood Retrospective Studies Differential Diagnosis Conformal Radiotherapy Endosonography Local Neoplasm Recurrence Dose Fractionation Antineoplastic Combined Chemotherapy Protocols radiotherapy Pancreatectomy Antineoplastic Agents Kaplan-Meier Estimate Adjuvant Chemotherapy chemically induced Lymphatic Metastasis metabolism Pancreatic Cyst Pancreatic Ductal Carcinoma pharmacology Magnetic Resonance Imaging Taxoids Incidence Portal Vein abnormalities Prostatic Neoplasms Survivors Follow-Up Studies Biological Models Intensity-Modulated Radiotherapy Enoxaparin Protein Transport Bile Duct Neoplasms Carcinoid Heart Disease adverse Algorithms physiopathology Neoplastic Gene Expression Regulation Double-Blind Method Genetic Polymorphism Phthalazines Urinary Bladder Neoplasms Cell Cycle Proteins Pancreas effects Antineoplastic Antimetabolites ELAV Proteins Thromboembolism Reconstructive Surgical Procedures Cultured Tumor Cells Fluorouracil Predictive Value of Tests Neutropenia Protein Kinase Inhibitors immunology Splenectomy BRCA2 Genes Syndrome Postoperative Complications BRCA1 Genes Neuroendocrine Tumors Mucinous Cystadenoma Celiac Artery Morbidity Hematologic Diseases Genetic Transcription physiology Drug Dose-Response Relationship Germ-Line Mutation Cetuximab Asymptomatic Diseases ultrastructure RecQ Helicases Computer-Assisted Radiotherapy Planning Vascular Neoplasms pharmacokinetics Neoplasm Invasiveness standards Biological Tumor Markers Laparoscopy Hematuria Genetic Epigenesis Genetic Databases Carcinoma in Situ Vomiting Mice Nausea Cell Proliferation Risk Assessment DNA Damage prevention & control Rectal Diseases Response Evaluation Criteria in Solid Tumors Tumor Cell Line Time Factors Drug Administration Schedule Mesenteric Veins Progression-Free Survival Regression Analysis Combined Modality Therapy Neoplasm Metastasis analogs & Imrt Cohort Studies Epithelial-Mesenchymal Transition RNA Interference Advisory Committees derivatives Anticoagulants Cancer Care Facilities
Last updated on Sunday, July 05, 2020